Preview: Alpine Immune Sciences's Earnings
Portfolio Pulse from Benzinga Insights
Alpine Immune Sciences (NASDAQ:ALPN) is scheduled to release its quarterly earnings report on March 18, 2024, with an estimated EPS of $-0.34. Historical data shows the company has previously beaten EPS estimates, leading to positive stock price movements. Shares have significantly appreciated over the last year, with a 344.61% increase. Investors are likely focused on both the earnings outcome and the company's future guidance.
March 15, 2024 | 3:00 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Alpine Immune Sciences is expected to report an EPS of $-0.34 for the upcoming quarter. Historical performance shows positive stock movement following earnings beats. With a 344.61% increase in share price over the last year, investor sentiment is likely positive.
Given ALPN's history of beating EPS estimates and the subsequent positive stock price reactions, there's a strong likelihood of a positive short-term impact if the trend continues. The significant annual stock appreciation indicates strong investor confidence, which could be further bolstered by a favorable earnings report and optimistic future guidance.
CONFIDENCE 80
IMPORTANCE 90
RELEVANCE 100